http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2424026-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_987d5da2d1b0bdbc1739144ed1222dc2 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-07 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35 |
| filingDate | 1979-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1979-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | FR-2424026-A1 |
| titleOfInvention | MEDICINAL PRODUCTS BASED ON HYDROSOLUBBLE HYDROXYFLAVON ETHERS FOR THE TREATMENT OF CONDITIONS ARISING FROM FRAGILITY AND PERMEABILITY OF BLOOD CAPILLARY |
| abstract | THESE MEDICINAL PRODUCTS ARE CONSTITUTED BY HYDROSOLUBLE HYDROXYFLAVON ETHERS, OBTAINED BY REACTION OF HYDROXYFLAVONS WITH SUBSTITUTED ALKYL HALOGENIDES, OF GENERAL FORMULA: (CF DRAWING IN BOPI) IN WHICH RHO-RAMOS OR 6-0 OR CHO-CHO-0 D-GLUCOSYL, RH OR CHCHOH AND RH OR CHCHOH. THEY ARE APPLIED IN HUMANS BY ORAL, RECTAL, PARENTERAL OR TOPICAL USE AT DOSES COMPRISED BETWEEN 50 AND 300MG, OF ACTIVE PRINCIPLE IN THE APPROPRIATE GALENIC FORMS, ALONE OR IN ASSOCIATED WITH OTHER SUBSTANCES OF SYNERGIC OR COMPLEMENTARY ACTIVITY, AT THE RATE OF 3 TO 8 DOSES PER DAY. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8503864-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8503865-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5096887-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0198965-A1 |
| priorityDate | 1978-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.